The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...
New release combines faster, higher resolution imaging for Medtronic cryoablation procedures KODEX-EPD system now installed at 40 sites worldwide with over 1500 patients treated Amsterdam, the ...
DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the ...
Medtronic had to overcome a major supplier glitch in its latest quarter as it tried to keep pace with other large medical-technology companies racing to commercialize new catheter technology that ...
Medtronic scored a double CE mark win for its PulseSelect pulsed field ablation (PFA) system, designed to treat atrial fibrillation, and the Nitron CryoConsole, designed to optimize workflow for ...
ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent ...
Pulsed field ablation using Boston Scientific Corp.’s Farapulse system was non-inferior and even superior, slightly, to Medtronic plc’s Artic Front Advance cardiac cryoablation system in treating ...
ATLANTA, March 15 (Reuters) - A noninvasive procedure that freezes and kills problem-causing heart tissue was nearly 10 times better at eliminating a potentially serious heart rhythm disorder than ...
CHICAGO (Reuters) - Medtronic Inc said on Thursday it agreed to buy Canada's CryoCath Technologies Inc for about $380 million (C$400 million) in a bid to strengthen its position in the growing market ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback